PublizoomAward notice Supplies
Totale Parenterale Nutritie
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Public buyer
- VITAZ vzw
Sint-Niklaas - Place of performance
- 9100 Sint-Niklaas, East Flanders
- Estimated value
- €1,456,000 excl. VAT
- Amount awarded
- €1,248,000 excl. VAT
- Planned end of contract
- 27 November 2029
likely re-tender around May 2029 - Bids received
- 2
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 11 December 2025
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Deze opdracht betreft het afsluiten van een raamovereenkomst met één opdrachtnemer waarbij alle voorwaarden voor de uitvoering van deze opdracht worden vastgelegd. Het doel van de raamovereenkomst is de levering van geneesmiddelen door de opdrachtnemer op afroep van de aanbesteder gedurende de looptijd beschreven in het bestek. De opdracht betreft zowel intramurale TPN als Home Parenterale Nutritie (HPN).
Awarded to
3 lots
- Ternaire mengsels met en zonder elektrolyten voor intramurale TPN en Homecare Parenterale Voeding (HPN)
- Vitaminen voor intraveneuze toediening
- Sporenelementen voor intraveneuze toediening
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33692200
Winning prices for comparable contracts
- A quarter below
- €444,216
- Median
- €606,904
- A quarter above
- €1,514,536
Amounts awarded (excl. VAT) over the last 3 years for 27 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Luspatercept VITAZ vzw · 22 October 2026 |
Orifarm Belgium | €3,000,000 |
| Ondansetron VITAZ vzw · 29 September 2026 |
Fresenius Kabi | €288,000 |
| Methotrexaat VITAZ vzw · 16 September 2026 |
Pharmanovia Benelux B.V. | €754,717 |
| Nintedanib VITAZ vzw · 17 July 2026 |
EG | €4,084,000 |
| Eltrombopag VITAZ vzw · 11 June 2026 |
ACCORD HEALTHCARE | €2,000,000 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 824557-2025.